A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC
Condition: HER2-positive Breast Cancer Intervention: Drug: Eribulin mesylate injection、Pertuzumab、Trastuzumab Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | HER2 | Herceptin | Hospitals | Neoadjuvant Therapy | Research